Review and feature articleAirway remodeling contributes to the progressive loss of lung function in asthma: An overview
Section snippets
Models of airway remodeling
A number of models have been used to characterize airway remodeling in asthma. Examination of lung tissues available at autopsy have shown that profound changes in airway morphology and structure have occurred in those that have died from asthma when compared with decedents with asthma dying from other causes and those without asthma.1 In vivo, characterization of airway biopsy specimens from living subjects with asthma have been compared with those from control subjects. Many studies
ASM remodeling
Airflow obstruction and AHR are a result of the contraction of ASM and hence indicate alterations in smooth muscle function. Several studies of patients dying from severe asthma have reported an increase in the apparent muscle mass within the airway wall in subjects with severe asthma when compared with control subjects.1, 10, 11 In histologic studies an increase in mass is assumed when there is an increase in the cross-sectional area occupied by ASM. Subjects with fatal asthma have been
Changes in inflammatory cells in airway remodeling
Despite the fact that airway inflammation has been known to be a prominent feature of asthma for decades, it still is not known whether inflammation drives the remodeling response in the airway wall or whether an intrinsic abnormality of airway structure or function drives inflammation. It has been widely assumed that allergic inflammation is the initiating event. A partial list of various asthma inflammatory mediators is presented in Table II.18, 29, 37, 38, 39, 40, 41, 42, 43, 44 There is no
Epithelial cell remodeling
Asthmatic airway biopsies, autopsy studies, and animal models all show that the epithelium is remodeled in asthma. Epithelial cells are found in increased amounts in asthmatic sputum, and epithelial detachment from the basement membrane is frequently observed in the various models of asthma. Moreover, there are a higher proportion of goblet cells in the asthmatic epithelium in vivo, and subepithelial mucus glands are enlarged.69
The epithelium forms the outer cellular barrier and serves
Asthmatic subepithelium and epithelial damage and repair
Underlying the bronchial epithelial cell layer is the lamina reticularis, also known as the reticular basement membrane (RBM; reviewed by Jeffery7). Several studies have reported that this layer is thickened, and this is a characteristic feature of airway remodeling in asthma. For example, Payne et al75 compared the thickness of the RBM in children with asthma who required moderately high doses of inhaled steroids with that in healthy children and adults with asthma. Interestingly, the
Conclusions
The clinical findings of asthma were initially identified many years ago and include reversible airflow obstruction, AHR, and mucus hypersecretion. Subsequently, histopathologic studies of airways from both animals and human subjects provided a structural basis for these clinical observations and led to the development of the concept of airways remodeling. Longitudinal studies of patients with asthma suggest that a progressive loss of lung function occurs in at least some asthmatic subjects.
References (87)
Similarities and differences in asthma and COPD. The Dutch hypothesis
Chest
(2004)- et al.
Synthetic responses in airway smooth muscle
J Allergy Clin Immunol
(2004) - et al.
Proliferative aspects of airway smooth muscle
J Allergy Clin Immunol
(2004) - et al.
Responsiveness of bronchial smooth muscle from asthmatic patients to relaxant and contractile agonists
Pulm Pharmacol
(1988) Airway smooth muscle: immunomodulatory cells that modulate airway remodeling?
Respir Physiol Neurobiol
(2003)- et al.
Transforming growth factor-beta (TGF-beta)
Int J Biochem Cell Biol
(1998) - et al.
Balance in asthma between matrix metalloproteinases and their inhibitors
J Allergy Clin Immunol
(1999) - et al.
The interplay of dendritic cells, Th2 cells and regulatory T cells in asthma
Curr Opin Immunol
(2004) - et al.
Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response
Lancet
(2000) - et al.
Evaluation of airway inflammation by endobronchial and transbronchial biopsy in nocturnal and nonnocturnal asthma
Chest
(1995)
Goblet cell and mucin gene abnormalities in asthma
Chest
Epithelial-mesenchymal interactions in the pathogenesis of asthma
J Allergy Clin Immunol
Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis
J Allergy Clin Immunol
The effect of age and duration of disease on airway structure in fatal asthma
Am J Respir Crit Care Med
Risk factors for growth and decline of lung function in asthmatic individuals up to age 42 years. A 30-year follow-up study
Am J Respir Crit Care Med
A 15-year follow-up study of ventilatory function in adults with asthma
N Engl J Med
Tenascin is increased in airway basement membrane of asthmatics and decreased by an inhaled steroid
Am J Respir Crit Care Med
Bronchial biopsies in asthma. An ultrastructural, quantitative study and correlation with hyperreactivity
Am Rev Respir Dis
Remodeling in asthma and chronic obstructive lung disease
Am J Respir Crit Care Med
Kinetics of the development and recovery of the lung from IgE-mediated inflammation: dissociation of pulmonary eosinophilia, lung injury, and eosinophil-active cytokines
Am J Respir Crit Care Med
Prolonged allergen challenge in mice leads to persistent airway remodelling
Clin Exp Allergy
Cellular hypertrophy and hyperplasia of airway smooth muscles underlying bronchial asthma. A 3-D morphometric study
Am Rev Respir Dis
Small airways dimensions in asthma and in chronic obstructive pulmonary disease
Am Rev Respir Dis
Effects of growth factors and extracellular matrix on survival of human airway smooth muscle cells
Am J Respir Cell Mol Biol
Regulation of cyclin D(1) expression and DNA synthesis by phosphatidylinositol 3-kinase in airway smooth muscle cells
Am J Respir Cell Mol Biol
MAPK superfamily activation in human airway smooth muscle: mitogenesis requires prolonged p42/p44 activation
Am J Physiol Lung Cell Mol Physiol
Mechanisms of proliferation synergy by receptor tyrosine kinase and G protein-coupled receptor activation in human airway smooth muscle
Am J Respir Cell Mol Biol
VIP inhibits basal and histamine-stimulated proliferation of human airway smooth muscle cells
Am J Physiol Lung Cell Mol Physiol
Mechanisms of cytokine effects on G protein-coupled receptor-mediated signaling in airway smooth muscle
Am J Physiol Lung Cell Mol Physiol
Antithetic regulation by beta-adrenergic receptors of Gq receptor signaling via phospholipase C underlies the airway beta-agonist paradox
J Clin Invest
Hyperplasia of smooth muscle in mild to moderate asthma without changes in cell size or gene expression
Am J Respir Crit Care Med
Cyclic AMP-mobilizing agents and glucocorticoids modulate human smooth muscle cell migration
Am J Respir Cell Mol Biol
Regulation of peroxisome proliferator-activated receptor gamma expression in human asthmatic airways: relationship with proliferation, apoptosis, and airway remodeling
Am J Respir Crit Care Med
Abnormalities in airway smooth muscle in fatal asthma. A comparison between trachea and bronchus
Am Rev Respir Dis
Hypothesis: excessive bronchoconstriction in asthma is due to decreased airway elastance
Eur Respir J
Mechanical factors determining maximum bronchoconstriction
Eur Respir J Suppl
A theoretical analysis of the effect of airway smooth muscle load on airway narrowing
Am J Respir Crit Care Med
Perhaps airway smooth muscle dysfunction contributes to asthmatic bronchial hyperresponsiveness after all
Am J Respir Cell Mol Biol
The mechanics of airway narrowing in asthma
Am Rev Respir Dis
The allergic mouse model of asthma: normal smooth muscle in an abnormal lung?
J Appl Physiol
Regulation of bronchomotor tone by lung inflation in asthmatic and nonasthmatic subjects
J Appl Physiol
Airway hyperresponsiveness in asthma: a problem of limited smooth muscle relaxation with inspiration
J Clin Invest
Changes in biophysical and biochemical properties of single bronchial smooth muscle cells from asthmatic subjects
Am J Physiol Lung Cell Mol Physiol
Cited by (294)
Dupilumab sustains lung function improvements in patients with moderate-to-severe asthma
2024, Respiratory MedicineAirway wall extracellular matrix changes induced by bronchial thermoplasty in severe asthma
2024, Journal of Allergy and Clinical ImmunologyL'asthme et l'allergie, rencontres de type 2
2023, Revue des Maladies Respiratoires Actualites
Series editor: Harold S. Nelson, MD
Supported in part by grants HL067663 and HL074225 to SPP.
Disclosure of potential conflict of interest: R. Pascual—none disclosed. S. Peters—As a member of the Wake Forest University Clinical Trials Group, Dr Peters has been involved in clinical trials supported by Abaris, AstraZeneca, Altana, Boehringer Ingelheim, Centocor, Genentech, GlaxoSmithKline, Novartis, Pfizer, and Wyeth. He has also performed consulting duties under the auspices of the National Institutes of Health, Adelphi, American Thoracic Society, AstraZeneca Pharmaceuticals, Discovery, Genentech, Novartis, Omnicare, RAND Corporation, Respiratory Medicine, Respiratory Research, and SanofiAventis. He has also participated in physician education programs (including speakers' bureaus) sponsored by the American College of Chest Physicians; American Lung Association; American Academy of Allergy, Asthma and Immunology; AstraZeneca; Merck; Genentech; Novartis; and the Respiratory and Allergic Disease (RAD) Foundation.